Literature DB >> 25526089

A unique role for p53 in the regulation of M2 macrophage polarization.

L Li1, D S W Ng2, W-C Mah3, F F Almeida4, S A Rahmat1, V K Rao5, S C Leow6, F Laudisi4, M T Peh2, A M Goh1, J S Y Lim7, G D Wright7, A Mortellaro4, R Taneja5, F Ginhoux4, C G Lee8, P K Moore2, D P Lane1.   

Abstract

P53 is critically important in preventing oncogenesis but its role in inflammation in general and in the function of inflammatory macrophages in particular is not clear. Here, we show that bone marrow-derived macrophages exhibit endogenous p53 activity, which is increased when macrophages are polarized to the M2 (alternatively activated macrophage) subtype. This leads to reduced expression of M2 genes. Nutlin-3a, which destabilizes the p53/MDM2 (mouse double minute 2 homolog) complex, promotes p53 activation and further downregulates M2 gene expression. In contrast, increased expression of M2 genes was apparent in M2-polarized macrophages from p53-deficient and p53 mutant mice. Furthermore, we show, in mice, that p53 also regulates M2 polarization in peritoneal macrophages from interleukin-4-challenged animals and that nutlin-3a retards the development of tolerance to Escherichia coli lipopolysaccharide. P53 acts via transcriptional repression of expression of c-Myc (v-myc avian myelocytomatosis viral oncogene homolog) gene by directly associating with its promoter. These data establish a role for the p53/MDM2/c-MYC axis as a physiological 'brake' to the M2 polarization process. This work reveals a hitherto unknown role for p53 in macrophages, provides further insight into the complexities of macrophage plasticity and raises the possibility that p53-activating drugs, many of which are currently being trialled clinically, may have unforeseen effects on macrophage function.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25526089      PMCID: PMC4572866          DOI: 10.1038/cdd.2014.212

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  21 in total

Review 1.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

Review 2.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

3.  Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology.

Authors:  Oscar M Pello; Maria De Pizzol; Massimiliano Mirolo; Laura Soucek; Luca Zammataro; Angelo Amabile; Andrea Doni; Manuela Nebuloni; Lamorna B Swigart; Gerard I Evan; Alberto Mantovani; Massimo Locati
Journal:  Blood       Date:  2011-11-08       Impact factor: 22.113

Review 4.  Protective and pathogenic functions of macrophage subsets.

Authors:  Peter J Murray; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2011-10-14       Impact factor: 53.106

Review 5.  Tumour-associated macrophages and cancer.

Authors:  Jenny Cook; Thorsten Hagemann
Journal:  Curr Opin Pharmacol       Date:  2013-06-15       Impact factor: 5.547

6.  p53 Attenuates lipopolysaccharide-induced NF-kappaB activation and acute lung injury.

Authors:  Gang Liu; Young-Jun Park; Yuko Tsuruta; Emmanuel Lorne; Edward Abraham
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

7.  p53 and NF-κB coregulate proinflammatory gene responses in human macrophages.

Authors:  Julie M Lowe; Daniel Menendez; Pierre R Bushel; Maria Shatz; Erin L Kirk; Melissa A Troester; Stavros Garantziotis; Michael B Fessler; Michael A Resnick
Journal:  Cancer Res       Date:  2014-04-15       Impact factor: 12.701

8.  Induction of IL-4Rα-dependent microRNAs identifies PI3K/Akt signaling as essential for IL-4-driven murine macrophage proliferation in vivo.

Authors:  Dominik Rückerl; Stephen J Jenkins; Nouf N Laqtom; Iain J Gallagher; Tara E Sutherland; Sheelagh Duncan; Amy H Buck; Judith E Allen
Journal:  Blood       Date:  2012-08-01       Impact factor: 22.113

9.  IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1.

Authors:  Stephen J Jenkins; Dominik Ruckerl; Graham D Thomas; James P Hewitson; Sheelagh Duncan; Frank Brombacher; Rick M Maizels; David A Hume; Judith E Allen
Journal:  J Exp Med       Date:  2013-10-07       Impact factor: 14.307

10.  Inhibition of nutlin-resistant HDM2 mutants by stapled peptides.

Authors:  Siau Jia Wei; Thomas Joseph; Sharon Chee; Ling Li; Larisa Yurlova; Kourosh Zolghadr; Christopher Brown; David Lane; Chandra Verma; Farid Ghadessy
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

View more
  51 in total

1.  YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction.

Authors:  Masum M Mia; Dasan Mary Cibi; Siti Aishah Binte Abdul Ghani; Weihua Song; Nicole Tee; Sujoy Ghosh; Junhao Mao; Eric N Olson; Manvendra K Singh
Journal:  PLoS Biol       Date:  2020-12-02       Impact factor: 8.029

2.  MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.

Authors:  Douglas D Fang; Qiuqiong Tang; Yanhui Kong; Qixin Wang; Jiaxing Gu; Xu Fang; Peng Zou; Tao Rong; Jingwen Wang; Dajun Yang; Yifan Zhai
Journal:  J Immunother Cancer       Date:  2019-11-28       Impact factor: 13.751

3.  cMyc-p53 feedback mechanism regulates the dynamics of T lymphocytes in the immune response.

Authors:  Harsha S Madapura; Daniel Salamon; Klas G Wiman; Sonia Lain; Eva Klein; Noémi Nagy
Journal:  Cell Cycle       Date:  2016-05-02       Impact factor: 4.534

4.  Macrophage Transcriptional Profile Identifies Lipid Catabolic Pathways That Can Be Therapeutically Targeted after Spinal Cord Injury.

Authors:  Y Zhu; K Lyapichev; D H Lee; D Motti; N M Ferraro; Y Zhang; S Yahn; C Soderblom; J Zha; J R Bethea; K L Spiller; V P Lemmon; J K Lee
Journal:  J Neurosci       Date:  2017-01-27       Impact factor: 6.167

Review 5.  Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies.

Authors:  C Raggi; H S Mousa; M Correnti; A Sica; P Invernizzi
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

Review 6.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

Review 7.  Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious Diseases.

Authors:  Robert N Mahon; Richard Hafner
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

Review 8.  p53 and the Carcinogenicity of Chronic Inflammation.

Authors:  Andrei V Gudkov; Elena A Komarova
Journal:  Cold Spring Harb Perspect Med       Date:  2016-11-01       Impact factor: 6.915

9.  STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma.

Authors:  Weiyun Li; Jun Xiao; Xin Zhou; Ming Xu; Chaobo Hu; Xiaoyan Xu; Yao Lu; Chang Liu; Shengjie Xue; Lei Nie; Haibin Zhang; Zhiqi Li; Yanbo Zhang; Fu Ji; Lijian Hui; Wufan Tao; Bin Wei; Hongyan Wang
Journal:  J Clin Invest       Date:  2015-10-12       Impact factor: 14.808

Review 10.  Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy.

Authors:  Alessandra Tuccitto; Eriomina Shahaj; Elisabetta Vergani; Simona Ferro; Veronica Huber; Monica Rodolfo; Chiara Castelli; Licia Rivoltini; Viviana Vallacchi
Journal:  Virchows Arch       Date:  2018-10-29       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.